While most cannabis -focused biotechs funnel their resources and time into the development of medicines using the two most common cannabinoids – tetrahydrocannabinol (THC) and cannabidiol (CBD) – InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) proprietary biosynthesis process has … Read More
The post Dangerous Opioid Side Effects Shift Market Focus to Cannabis for appeared first on Dagga Magazine.